>

MEETINGS / EVENTS

RSS

May 05 - 07 2014, 12:00 AM - 12:00 AM

2014 ASA Legislative Conference

>

FDA MEDWATCH ALERTS

March 28, 2014

FDA Update on the Shortage of Normal Saline

Summary:

FDA Update on the Shortage of Normal Saline

March 18, 2014

FDA MedWatch - Merit Medical Systems, Custom Procedural Trays/Kits Containing 1 percent Lidocaine HCl Injection, 10mg/mL: Recall - Particulates Found in Hospira supplied Lidocaine

Summary:

Merit Medical Systems Custom Procedural Trays Kits Recall Particulates Found in Hospira Lidocaine

March 18, 2014

McKesson Technologies Anesthesia Care: Recall - Patient Case Data May Not Match Patient Data

Summary:

McKesson Technologies Anesthesia Care Recall Patient Case Data May Not Match Patient Data

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

Template 4

The World Health Organization (WHO) analgesic ladder consists of a hierarchy of oral pharmacologic interventions designed to effectively treat pain of increasing magnitude. The ladder presents a framework for the rational use of oral medication before application of other techniques of drug administration. Opioid therapy is considered the mainstay approach for patients with moderate or severe pain. The type of medication administered is sequentially escalated from nonopioids (e.g., nonsteroidal antiinflammatory drugs (NSAIDs) adjuvants to opioids used for mild to moderate pain (codeine, dihydrocodeine, oxycodone (compounded with a coanalgesic), hydrocodone, dihydrocodone) adjuvants to opioids commonly used for severe pain (morphine, hydromorphone, methadone, oxycodone (without compounding), fentanyl or levorphanol). Adjuvant medications are listed in template 7. (Modified with permission from WHO: Cancer pain relief and palliative care: Report of a WHO expert committee. Geneva, World Health Organization, 1990 (technical report series, no. 804).)